The First Store System

Chapter 770: Assistant Selection(7)

Time flew by, and fifty more years passed in a flash.

"I DID IT!"

Evelyn jumped in jubilation as her research of more than seventy years finally bore her fruit. Even someone like her, who had lived for a long couldn't control herself from jumping in joy.

"How many new recipes do we have?" Evelyn took a deep breath as she calmed her excited heart down. She then tapped on the device and asked.

"We have seven different recipes for Rutarat, three new recipes for Ghaorat..., one recipe for Jugurat," A voice came with shocking answers from the other side.

(A/N: I randomly name the diseases, with rat constant at the end.)

"Our wait over these years isn't without result," Evelyn mumbled as the results were beyond her expectation.

"Madam, do you want us to the public these new medicines?" A question rang from the device as the man on the other side understood the context of his boss's words.

"Not right now. I have just succeeded in my research. I need some more time," Evelyn answered after staying silent for some time.

The cost of having this group of best minds works for Evelyn and her business over these years had been enormous.

For the last ten years, the amount was coming straight out of Evelyn's pocket to pay salaries to these scientists.

Fifty years of time was more than enough for an old business to die and a new company to thrive. Since Evelyn's store had failed to provide any new recipes over the past several decades, the popularity of the store declined.

Evelyn's monopoly over the province also disappeared as a medical company from another state took over the disgruntled consumer base of Evelyn's store.

Time flew by, and two years later, Evelyn decided to announce the new recipes to the public.

That day in evening, the entire province saw a television advertisement. A few cities in the nearby provinces also ran Evelyn's advertisement since she splurged a lot on it.

Fifty years was a long duration of time for ordinary people, but for the rich who could afford life-extension medicines, it was just another period of time.

"From this moment, we humans have won over Guratorat. Now, there is no fatal disease that we humans haven't won over," Evelyn announced in the ad, taking the entire province by storm.

Guratorat was the only disease that humanity, with all its technology, had failed to conquer. Even though only one in the billion got diagnosed with the disease, it was still fatal and something that humans have no chance of winning over.

Now that Evelyn found the vaccine of Guratorat, there was no disease that was capable of killing a human, a wealthy human at that.

Evelyn's announcement took the province by storm, and in no time, her wealth grew by several times since she already got several orders of the Guratorat vaccine.

The wealthy of any world had the need of hoarding materials, so when they heard that now even Guratorat wasn't capable of killing them, they ordered its vaccine, ignoring the expensive cost.

The vaccine for Guratorat wasn't publically available since it was very expensive, but its presence did wonders for Evelyn's medical store.

In no time, Evelyn regained her monopoly over the province, and five years after her announcement, she began her expansion.

In the next thirty years, she splurged money like water to have a stable foothold for her store, and her efforts weren't for naught.

When Evelyn reached the age of two hundred years old, her medical store had turned into a colossus that controlled an entire state.

There were seventeen states in the world, with each state having thirty provinces.

Evelyn then slowed down her expansion plans. She instead returned to her research. This time her focus was on life-extension medicines.

Currently, there was only a single type of life-extension medicine available on the market.

When any person ate the life-extension medicine for the first time, they would gain a lifespan of two hundred years old. The second use would only grant a lifespan of hundred years.

Its effects would become half with every use, so a person could only live for around five hundred years at most.

It was also the reason Aakesh had set the deadline of the contest as five hundred years since there was no way to live beyond that if the technology of life extension remained the same.

In the beginning, Evelyn had decided to delve into another venture after entirely focusing on medicine for two hundred years. But now that she was only seventeen years away from that timeline, she pushed that step in her journey forward by another hundred years.

Evelyn believed that evolving life-extension medicines would result in her exploding in the financial market. As for how much it would help her, she didn't know.

Without caring about the passing of time, Evelyn and her group of scientists delved themselves into the research of life extension.

Around twenty years later, one of the brilliant scientists in the group died as he had already used life-extension medicine to its limit, and he couldn't increase his lifespan even further.

The sudden death of a teammate took the group by shock, but at the same time, it made them even more determined to succeed.

When Evelyn was two hundred and fifty-seven years of age, a new disease took the world by storm. Evelyn and her team had no other choice but to stop their research and focus on this new disease since it had already killed more than twenty million people.

One day while studying the genome of the disease, Evelyn suddenly had an epiphany. She then began studying the virus of Guratorat.

Evelyn couldn't help but exclaim in surprise as she discovered the genome to be matching more than fifty percent. Her shock didn't just end there as she found the same genome in the life-extension medicine.

That day, Evelyn's research in life-extension medicine saw a sudden increase.

Evelyn's company was one step behind when another company from a different state became the first company to find the vaccine for the new disease attacking humanity.

Seven years later, Evelyn took the world by storm as she announced a new type of life-extension medicine.